Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy

Scientific Reports
Yong Chul KimJung Pyo Lee

Abstract

Hepatocyte growth factor and its receptor cMet activate biological pathways necessary for repair and regeneration following kidney injury. Here, we evaluated the clinical role of urinary cMet as a prognostic biomarker in diabetic nephropathy (DN). A total of 218 patients with DN were enrolled in this study. We examined the association of urine cMet levels and long-term outcomes in patients with DN. The levels of urinary cMet were higher in patients with decreased renal function than in patients with relatively preserved renal function (5.25 ± 9.62 ng/ml versus 1.86 ± 4.77 ng/ml, P = 0.001). A fully adjusted model revealed that a urinary cMet cutoff of 2.9 ng/mL was associated with a hazard ratio for end-stage renal disease of 2.33 (95% confidence interval 1.19-4.57, P = 0.014). The addition of urinary cMet to serum creatinine and proteinuria provided the highest net reclassification improvement. We found that in primary cultured human glomerular endothelial cells, TGFβ treatment induced fibrosis, and the protein expression levels of collagen I, collagen IV, fibronectin, and αSMA were decreased after administration of an agonistic cMet antibody. In conclusion, elevated levels of urinary cMet at the time of initial diagnosis coul...Continue Reading

References

Sep 18, 2002·Kidney International·Xiaojie GaoTakakuni Tanizawa
Oct 2, 2003·American Journal of Physiology. Renal Physiology·Shinya Mizuno, Toshikazu Nakamura
Jun 8, 2004·American Journal of Physiology. Renal Physiology·Youhua Liu
Oct 7, 2004·Journal of the American Society of Nephrology : JASN·Chunsun DaiYouhua Liu
Mar 28, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Cheuk-Chun SzetoFernand Mac-Moune Lai
Oct 12, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Rulan S ParekhUNKNOWN Family Investigation of Nephropathy and Diabetes Research Group
Feb 13, 2009·Clinical and Translational Science·Vishal S VaidyaJoseph V Bonventre
Apr 30, 2009·Diabetes·Per-Henrik GroopUNKNOWN FinnDiane Study Group
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jul 16, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Nattachai SrisawatJohn A Kellum
Jul 19, 2011·The American Journal of Pathology·Sonsoles Piera-VelazquezSergio A Jimenez
Jan 24, 2012·Journal of the American Society of Nephrology : JASN·Monika A NiewczasAndrzej S Krolewski
Aug 2, 2012·Diabetes Care·Andrzej S KrolewskiPer-Henrik Groop
Aug 27, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jiangzi YuanBengt Lindholm
Nov 10, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Chirag R ParikhUNKNOWN ASSESS-AKI Study Investigators
Aug 29, 2014·The Journal of Clinical Endocrinology and Metabolism·Elaine HuiKaren S L Lam
Nov 2, 2014·Molecular Endocrinology·Juan C Alvarez-PerezAdolfo García-Ocaña
Dec 24, 2014·Journal of the American Society of Nephrology : JASN·Sandhya XavierMichael S Goligorsky
May 15, 2015·Journal of Diabetes Investigation·Chi-Ho Lee, Karen Siu Ling Lam
Sep 16, 2016·American Journal of Physiology. Renal Physiology·Kapil Sareen-KhannaAndrey V Cybulsky
Feb 19, 2017·Cell Communication and Signaling : CCS·Ralf HassKarlheinz Friedrich
Apr 25, 2017·Diabetes Research and Clinical Practice·K OgurtsovaL E Makaroff
Dec 30, 2017·Kidney Research and Clinical Practice·Seung Hee YangJung Pyo Lee

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
biopsy
confocal microscopy
PCR

Software Mentioned

SPSS
R
Analyst
Multi

Related Concepts

Related Feeds